Where does Wugen's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Wugen's 2 recorded funding rounds.

Premier Alternatives

Wugen

Drug Discovery · Saint Louis, MO · Founded 2018 · Privately Held (backing)

Developer of off-the-shelf cell therapy technology designed to treat hematologic and solid tumor cancers. Wugen is based in Saint Louis, MO and was founded in 2018. It is valued at about $215 million as of Oct 2026, set by institutional fund marks, down 12% since its later-stage round in Aug 2025. It has raised $323 million across 2 recorded rounds; the latest was an $115 million Series C in Aug 2025.

PMV mark · valuation

$214.5M

Oct 2026

Since last round

-12%

Aug 2025

Total raised

$323.0M

Last round

Later Stage VC (Series C)

Aug 2025

Cap table — not yet on record

Wugen's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on Wugen

·84 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about Wugen

Where does Wugen's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Wugen's 2 recorded funding rounds.